Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Shah, Sohrab P.
Автор Roth, Andrew
Автор Goya, Rodrigo
Автор Oloumi, Arusha
Автор Ha, Gavin
Автор Zhao, Yongjun
Автор Turashvili, Gulisa
Автор Ding, Jiarui
Автор Tse, Kane
Автор Haffari, Gholamreza
Автор Bashashati, Ali
Автор Prentice, Leah M.
Автор Khattra, Jaswinder
Автор Burleigh, Angela
Автор Yap, Damian
Автор Bernard, Virginie
Автор McPherson, Andrew
Автор Shumansky, Karey
Автор Crisan, Anamaria
Автор Giuliany, Ryan
Автор Heravi-Moussavi, Alireza
Автор Rosner, Jamie
Автор Lai, Daniel
Автор Birol, Inanc
Автор Varhol, Richard
Автор Tam, Angela
Автор Dhalla, Noreen
Автор Zeng, Thomas
Автор Ma, Kevin
Автор Chan, Simon K.
Автор Griffith, Malachi
Автор Moradian, Annie
Автор Cheng, S.-W. Grace
Автор Morin, Gregg B.
Автор Watson, Peter
Автор Gelmon, Karen
Автор Chia, Stephen
Автор Chin, Suet-Feung
Автор Curtis, Christina
Автор Rueda, Oscar M.
Автор Pharoah, Paul D.
Автор Damaraju, Sambasivarao
Автор Mackey, John
Автор Hoon, Kelly
Автор Harkins, Timothy
Автор Tadigotla, Vasisht
Автор Sigaroudinia, Mahvash
Автор Gascard, Philippe
Автор Tlsty, Thea
Автор Costello, Joseph F.
Автор Meyer, Irmtraud M.
Автор Eaves, Connie J.
Автор Wasserman, Wyeth W.
Автор Jones, Steven
Автор Huntsman, David
Автор Hirst, Martin
Автор Caldas, Carlos
Автор Marra, Marco A.
Автор Aparicio, Samuel
Дата выпуска 2012
dc.description Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately 16% of all breast cancers. Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations. High-throughput RNA sequencing (RNA-seq) revealed that only approximately 36% of mutations are expressed. Using deep re-sequencing measurements of allelic abundance for 2,414 somatic mutations, we determine for the first timeâ to our knowledgeâ in an epithelial tumour subtype, the relative abundance of clonal frequencies among cases representative of the population. We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC showing more variation than non-basal TNBC. Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumours their clonal frequencies are incompatible with founder status. Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumour progression. Taken together, our results show that understanding the biology and therapeutic responses of patients with TNBC will require the determination of individual tumour clonal genotypes.
Формат application.pdf
Издатель Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Копирайт Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Название The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Тип LETTERS TO NATURE
DOI 10.1038/nature10933
Print ISSN 0028-0836
Журнал Nature
Аффилиация Shah, Sohrab P.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Roth, Andrew; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Goya, Rodrigo; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Oloumi, Arusha; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Ha, Gavin; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Zhao, Yongjun; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Turashvili, Gulisa; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Ding, Jiarui; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Tse, Kane; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Haffari, Gholamreza; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Bashashati, Ali; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Prentice, Leah M.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Khattra, Jaswinder; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Burleigh, Angela; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Yap, Damian; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Bernard, Virginie; Centre for Molecular Medicine and Therapeutics, 950 West 28th Avenue, Vancouver, British Columbia V5Z 4H4, Canada
Аффилиация McPherson, Andrew; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Shumansky, Karey; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Crisan, Anamaria; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Giuliany, Ryan; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Heravi-Moussavi, Alireza; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Rosner, Jamie; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Lai, Daniel; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Birol, Inanc; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Varhol, Richard; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Tam, Angela; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Dhalla, Noreen; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Zeng, Thomas; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Ma, Kevin; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Chan, Simon K.; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Griffith, Malachi; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Moradian, Annie; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Cheng, S.-W. Grace; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Morin, Gregg B.; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Аффилиация Watson, Peter; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada
Аффилиация Gelmon, Karen; British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada
Аффилиация Chia, Stephen; British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada
Аффилиация Chin, Suet-Feung; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK
Аффилиация Curtis, Christina; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
Аффилиация Rueda, Oscar M.; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK
Аффилиация Pharoah, Paul D.; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK
Аффилиация Damaraju, Sambasivarao; Departments of Oncology and Laboratory Medicine and Pathology, University of Alberta, 11560 University Avenue, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
Аффилиация Mackey, John; Departments of Oncology and Laboratory Medicine and Pathology, University of Alberta, 11560 University Avenue, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
Аффилиация Hoon, Kelly; Life Technologies, 101 Lincoln Centre Dr., Foster City, California 94404, USA
Аффилиация Harkins, Timothy; Life Technologies, 101 Lincoln Centre Dr., Foster City, California 94404, USA
Аффилиация Tadigotla, Vasisht; Life Technologies, 101 Lincoln Centre Dr., Foster City, California 94404, USA
Аффилиация Sigaroudinia, Mahvash; Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
Аффилиация Gascard, Philippe; Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
Аффилиация Tlsty, Thea; Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
Аффилиация Costello, Joseph F.; Brain Tumor Research Center, Department of Neurosurgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143, USA
Аффилиация Meyer, Irmtraud M.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada; Department of Computer Science, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada; Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
Аффилиация Eaves, Connie J.; Terry Fox Laboratory, BC Cancer Agency, 675 W 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada
Аффилиация Wasserman, Wyeth W.; Centre for Molecular Medicine and Therapeutics, 950 West 28th Avenue, Vancouver, British Columbia V5Z 4H4, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Аффилиация Jones, Steven; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada; Department of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Dr., Burnaby, British Columbia V5A1S6, Canada
Аффилиация Huntsman, David; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada; Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Ave, Vancouver, British Columbia V5Z 4E6, Canada
Аффилиация Hirst, Martin; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada; Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada; Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Аффилиация Caldas, Carlos; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Breast Unit, Addenbrookes Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cambridge Experimental Cancer Medicine Centre (ECMC), Cambridge CB2 0RE, UK
Аффилиация Marra, Marco A.; Canadaâ s Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Аффилиация Aparicio, Samuel; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada

Скрыть метаданые